Cargando…

The Efficacy and Safety of Intermittent Low-Dose Urokinase Thrombolysis for the Treatment of Senile Acute Intermediate-High-Risk Pulmonary Embolism: A Pilot Trial

Thrombolysis and anticoagulation were the main treatment methods for acute pulmonary embolism. However, the use of thrombolysis drugs may lead to bleeding complications. We compared intermittent low-dose urokinase (UK) and alteplase (recombinant tissue plasminogen activator [rt-PA]) in normotensive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Tianming, Ni, Jixiang, Hu, Xuehua, Wang, Yingnan, Du, Xinge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714758/ https://www.ncbi.nlm.nih.gov/pubmed/29552916 http://dx.doi.org/10.1177/1076029618758953

Ejemplares similares

Urokinase versus Alteplase in Patients with Intermediate–High-Risk Pulmonary Embolism Treated with Ultrasound-Accelerated Endovascular Thrombolysis
por: Al-Terki, Hani, et al.
Publicado: (2023)

Safety and Efficacy of Low Dosage of Urokinase for Catheter-directed Thrombolysis of Deep Venous Thrombosis
por: Du, Xiao-Long, et al.
Publicado: (2015)

Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial
por: Sanchez, Olivier, et al.
Publicado: (2021)

Low-dose thrombolysis for submassive pulmonary embolism
por: Yilmaz, Emine Serap, et al.
Publicado: (2021)

Low-dose urokinase thrombolytic therapy for patients with acute intermediate-high-risk pulmonary embolism: A retrospective cohort study
por: Weng, Cuilian, et al.
Publicado: (2021)

The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis
por: Zhao, Tianming, et al.
Publicado: (2018)

Catheter-Directed Thrombolysis With a Continuous Infusion of Low-Dose Alteplase for Subacute Proximal Venous Thrombosis: Efficacy and Safety Compared to Urokinase
por: Gong, Maofeng, et al.
Publicado: (2018)

Low dose peripheral systemic thrombolysis for treatment of intermediate–high risk acute pulmonary embolism: a case series
por: Charif, Fida, et al.
Publicado: (2022)

Successful treatment of submassive pulmonary embolism with right ventricle strain using ultrasound-assisted thrombolysis with urokinase: a case report
por: Al-Terki, Hani, et al.
Publicado: (2023)

In-Vitro Study of Urokinase Thrombolysis Following Stereotactic Aspiration of Intracerebral Hematoma
por: Son, Wonsoo, et al.
Publicado: (2020)

Pulmonary artery catheter-directed thrombolysis for intermediate high risk acute pulmonary embolism
por: Singh, Abhijeet, et al.
Publicado: (2017)

A systematic review for the role of systemic thrombolysis in intermediate-risk (submassive) pulmonary embolism
por: Seif, Mohamed Ahmed
Publicado: (2020)

Corrigendum to: Low dose peripheral systemic thrombolysis for treatment of intermediate–high risk acute pulmonary embolism: a case series
Publicado: (2022)

The Safety and Efficacy of Ultrasound-Accelerated Catheter-Directed Thrombolysis in Patients with Intermediate–High-Risk Pulmonary Embolism: Bo-NE-Experience
por: Al-Terki, Hani, et al.
Publicado: (2023)

Outcomes and Treatment Complications of Intravenous Urokinase Thrombolysis in Acute Ischemic Stroke in China
por: Zhang, Rongrong, et al.
Publicado: (2021)

cRGD Urokinase Liposomes for Thrombolysis in Rat Model of Acute Pulmonary Microthromboembolism
por: Liang, Chunting, et al.
Publicado: (2022)

Construction of ultrasound-responsive urokinase precise controlled-release nanoliposome applied for thrombolysis
por: Fan, Yongliang, et al.
Publicado: (2022)

Safe and effective thrombolysis in free flap salvage: Intra-arterial urokinase infusion
por: Kim, Jun Hyeok, et al.
Publicado: (2023)

Lifting the fog in intermediate-risk (submassive) PE: full dose, low dose, or no thrombolysis?
por: Bhamani, Amyn, et al.
Publicado: (2019)

The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta‐analysis
por: Alcedo, Pedro E., et al.
Publicado: (2020)

Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: systematic review and network meta-analysis
por: Planer, David, et al.
Publicado: (2023)

Assessment of the value of 3D-DSA combined with neurointerventional thrombolysis in the treatment of senile cerebrovascular occlusion
por: Jiao, Song, et al.
Publicado: (2020)

EKOS(TM) in Octogenarians: The Safety and Efficacy of Ultrasound-Accelerated Catheter-Directed Thrombolysis in Elderly Patients with Intermediate-High-Risk Pulmonary Embolism
por: Al-Terki, Hani, et al.
Publicado: (2023)

Catheter-Directed Thrombolysis with a Continuous Infusion of Low-Dose Urokinase for Non-Acute Deep Venous Thrombosis of the Lower Extremity
por: Gao, Binbin, et al.
Publicado: (2011)

Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction
por: Sun, Fan, et al.
Publicado: (2020)

Balloon-Assisted Thrombectomy and Intrasinus Urokinase Thrombolysis for Severe Cerebral Venous Sinus Thrombosis
por: Yang, Jiansheng, et al.
Publicado: (2021)

Reperfusion of occluded branch retinal arteries by transluminal Nd:YAG laser embolysis combined with intravenous thrombolysis of urokinase
por: Chai, Fang, et al.
Publicado: (2018)

Ultrasound-assisted catheter-directed thrombolysis compared with anticoagulation alone for treatment of intermediate-risk pulmonary embolism
por: Schissler, Andrew J., et al.
Publicado: (2018)

Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase
por: Wójtowicz, Dominika, et al.
Publicado: (2018)

Senility, Senile Dementia and Their Medicolegal Aspects
por: Stephenson, F. H.
Publicado: (1901)

Thrombolysis with reteplase in acute pulmonary embolism
por: Nishanth, K.R., et al.
Publicado: (2019)

Safety and efficacy of catheter directed thrombolysis (CDT) in elderly with pulmonary embolism (PE)
por: Harrison, Eneida, et al.
Publicado: (2021)

Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial
por: Wang, Chen, et al.
Publicado: (2009)

Intermittency at intermediate energies
por: Kittel, E W, et al.
Publicado: (1991)

Evaluation of the efficacy and safety of artemether emulsion on localized senile pruritus: A randomized pilot study
por: He, Hui-Qiong, et al.
Publicado: (2022)

Cyclic RGD functionalized PLGA nanoparticles loaded with noncovalent complex of indocyanine green with urokinase for synergistic thrombolysis
por: Zhang, Sha, et al.
Publicado: (2022)

Tough decisions in pulmonary embolism: thrombolysis or embolectomy?
por: Liew, Alphonsus, et al.
Publicado: (2016)

Thrombolysis in Acute Pulmonary Embolism: Are we overdoing it?
por: Showkathali, Refai, et al.
Publicado: (2021)

EKOS™ Jena Experience: Safety, Feasibility, and Midterm Outcomes of Percutaneous Ultrasound-Assisted Catheter-Directed Thrombolysis in Patients with Intermediate-High-Risk or High-Risk Pulmonary Embolism
por: Klein, Friederike, et al.
Publicado: (2022)

Systemic thrombolysis with newer thrombolytics vs anticoagulation in acute intermediate risk pulmonary embolism: a systematic review and meta-analysis
por: Mathew, Don, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p1v3gho4e7j4l17u13ffj58hpc